GIGROUP: strona spółki
30.09.2021, 17:24
WSE Making public of delayed confidential information concerning negotiations by the Issuer regarding the determination of the terms of sale of all shares in Prohumán 2004 Kft.
Pursuant to Art. 17(1) and (4) of Regulation no. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (“MAR Regulation”), The Management Board of Work Service S.A. ("Issuer" or "Company"), communicates the confidential information, the public disclosure of which was delayed by the Company on 9 June 2021 pursuant to Art. 17(4) of the MAR Regulation, with the following wording:
The Management Board of the Company informs that it is negotiating the sale of all its shares in the Issuer's subsidiary, Prohumán 2004 Kft. ("Prohuman") (representing 80.22% of the total share capital of Prohuman) ("Transaction"), in the course of which the Company applied to the lending banks for consent to conduct - in the event of a positive conclusion of the negotiations - Transaction on preliminary terms negotiated by the parties. The Issuer's actions towards the implementation of the Transaction are the result of concluding a cooperation agreement in the implementation of the second process of selling all shares of Work Service S.A. in Prohuman, about which the Issuer informed in the current report 108/2020. The sale in question depends on the parties negotiating satisfactory terms of the Transaction. The Issuer hereby clarifies that the disclosure of this information is performed due to the need to apply to the accounting standards resulting from the arrangements with the Issuer's auditor requiring the disclosure of the intended sale of shares in Prohumán as assets for sale in the semi-annual financial statements, which will be published on 30 September 2021. The conclusion of an agreement for the sale of shares in Prohuman, assuming a successful course of negotiations, will be conditional on obtaining all necessary permits resulting from the provisions of the law of commercial companies and resulting from agreements linking the Issuer with the Issuer's Crediting Banks. If the negotiations are successful, the Issuer will immediately publish information about it in the form of an appropriate current report. As a result of the analysis carried out, the Issuer assumed that qualification of the above-mentioned information as confidential within the meaning of Art. 17 (1) MAR, subject to publication in the form of this report, is justified. Legal basis: Art. 17(1) and (4) of MAR (Regulation EU no. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC. Signatures: Iwona Szmitkowska – President of the Management Board Paolo Caramello - Vice-President of the Management Board
The Management Board of the Company informs that it is negotiating the sale of all its shares in the Issuer's subsidiary, Prohumán 2004 Kft. ("Prohuman") (representing 80.22% of the total share capital of Prohuman) ("Transaction"), in the course of which the Company applied to the lending banks for consent to conduct - in the event of a positive conclusion of the negotiations - Transaction on preliminary terms negotiated by the parties. The Issuer's actions towards the implementation of the Transaction are the result of concluding a cooperation agreement in the implementation of the second process of selling all shares of Work Service S.A. in Prohuman, about which the Issuer informed in the current report 108/2020. The sale in question depends on the parties negotiating satisfactory terms of the Transaction. The Issuer hereby clarifies that the disclosure of this information is performed due to the need to apply to the accounting standards resulting from the arrangements with the Issuer's auditor requiring the disclosure of the intended sale of shares in Prohumán as assets for sale in the semi-annual financial statements, which will be published on 30 September 2021. The conclusion of an agreement for the sale of shares in Prohuman, assuming a successful course of negotiations, will be conditional on obtaining all necessary permits resulting from the provisions of the law of commercial companies and resulting from agreements linking the Issuer with the Issuer's Crediting Banks. If the negotiations are successful, the Issuer will immediately publish information about it in the form of an appropriate current report. As a result of the analysis carried out, the Issuer assumed that qualification of the above-mentioned information as confidential within the meaning of Art. 17 (1) MAR, subject to publication in the form of this report, is justified. Legal basis: Art. 17(1) and (4) of MAR (Regulation EU no. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC. Signatures: Iwona Szmitkowska – President of the Management Board Paolo Caramello - Vice-President of the Management Board